Articoli con mandati relativi all'accesso pubblico - Morag ParkUlteriori informazioni
Non disponibili pubblicamente: 9
Controlla
Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity
G Deblois, JA Hall, MC Perry, J Laganiere, M Ghahremani, M Park, ...
Cancer research 69 (15), 6149-6157, 2009
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Controlla
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptor
MM Frigault, MA Naujokas, M Park
Journal of cellular physiology 214 (3), 694-705, 2008
Mandati: Canadian Institutes of Health Research
Controlla
MS/MS‐based strategies for proteomic profiling of invasive cell structures
S Havrylov, M Park
Proteomics 15 (2-3), 272-286, 2015
Mandati: Canadian Institutes of Health Research
Controlla
Laser capture microdissection as a tool to study tumor stroma
NR Bertos, M Park
The Tumor Microenvironment: Methods and Protocols, 13-25, 2016
Mandati: Fonds de recherche du Québec - Santé
Controlla
HER2Δ16 engages ENPP1 to promote an immune-cold microenvironment in breast cancer
SS Attalla, J Boucher, H Proud, T Taifour, D Zuo, V Sanguin-Gendreau, ...
Cancer immunology research 11 (9), 1184-1202, 2023
Mandati: Canadian Cancer Society, Canadian Institutes of Health Research, Fonds de …
Controlla
Inferring Copy Number from Triple-Negative Breast Cancer Patient Derived Xenograft scRNAseq Data Using scCNA
E Kuzmin, J Monlong, C Martinez, H Kuasne, CL Kleinman, J Ragoussis, ...
Mapping Genetic Interactions, 285-303, 2021
Mandati: Wellcome Trust
Controlla
Covalent protein modification as a mechanism for dynamic recruitment of specific interactors
NR Bertos, V Sangwan, XJ Yang, M Park
Post-Translational Modifications in Health and Disease, 259-279, 2011
Mandati: Canadian Institutes of Health Research
Controlla
Tumors and Their Microenvironments
NR Bertos, M Park
Cancer Systems Biology, 261-281, 2010
Mandati: Canadian Institutes of Health Research
Controlla
Role of Stroma in Disease Progression
NR Bertos, M Park
Experimental and Clinical Metastasis: A Comprehensive Review, 129-147, 2013
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Disponibili pubblicamente: 141
Controlla
Stromal gene expression predicts clinical outcome in breast cancer
G Finak, N Bertos, F Pepin, S Sadekova, M Souleimanova, H Zhao, ...
Nature medicine 14 (5), 518-527, 2008
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ...
Cancer cell 22 (1), 21-35, 2012
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Controlla
Pten in stromal fibroblasts suppresses mammary epithelial tumours
AJ Trimboli, CZ Cantemir-Stone, F Li, JA Wallace, A Merchant, N Creasap, ...
Nature 461 (7267), 1084-1091, 2009
Mandati: US National Institutes of Health
Controlla
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
T Gruosso, M Gigoux, VSK Manem, N Bertos, D Zuo, I Perlitch, SMI Saleh, ...
The Journal of clinical investigation 129 (4), 1785-1800, 2019
Mandati: US National Institutes of Health, Fonds de recherche du Québec - Santé
Controlla
miR-378∗ mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway
LJ Eichner, MC Perry, CR Dufour, N Bertos, M Park, J St-Pierre, V Giguère
Cell metabolism 12 (4), 352-361, 2010
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Controlla
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
A Bronisz, J Godlewski, JA Wallace, AS Merchant, MO Nowicki, ...
Nature cell biology 14 (2), 159-167, 2012
Mandati: US National Institutes of Health
Controlla
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
MG Ponzo, R Lesurf, S Petkiewicz, FP O'Malley, D Pinnaduwage, ...
Proceedings of the National Academy of Sciences 106 (31), 12903-12908, 2009
Mandati: Canadian Institutes of Health Research
Controlla
Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Y Du, H Yamaguchi, Y Wei, JL Hsu, HL Wang, YH Hsu, WC Lin, WH Yu, ...
Nature medicine 22 (2), 194-201, 2016
Mandati: US National Institutes of Health, Susan G. Komen
Controlla
ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties
AAN Rose, MG Annis, Z Dong, F Pepin, M Hallett, M Park, PM Siegel
PloS one 5 (8), e12093, 2010
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Controlla
Regulation of endocytosis via the oxygen-sensing pathway
Y Wang, O Roche, MS Yan, G Finak, AJ Evans, JL Metcalf, BE Hast, ...
Nature medicine 15 (3), 319-324, 2009
Mandati: Canadian Institutes of Health Research
Controlla
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
AAN Rose, AA Grosset, Z Dong, C Russo, PA MacDonald, NR Bertos, ...
Clinical cancer research 16 (7), 2147-2156, 2010
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software